4//SEC Filing
Rossi Christina 4
Accession 0001415889-25-012250
CIK 0001597264other
Filed
May 6, 8:00 PM ET
Accepted
May 7, 4:32 PM ET
Size
11.2 KB
Accession
0001415889-25-012250
Insider Transaction Report
Form 4
Rossi Christina
CHIEF OPERATING OFFICER
Transactions
- Sale
Common Stock
2025-05-05$101.77/sh−1,343$136,677→ 67,316 total - Sale
Common Stock
2025-05-05$102.82/sh−180$18,508→ 67,136 total - Sale
Common Stock
2025-05-05$100.97/sh−607$61,289→ 68,659 total - Sale
Common Stock
2025-05-05$103.56/sh−144$14,913→ 66,992 total
Footnotes (5)
- [F1]Effected pursuant to a trading plan adopted on August 27, 2024 pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
- [F2]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $100.32 to $101.32. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $101.33 to $102.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $102.34 to $103.30. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported is an average sale price. The shares were sold in multiple transactions ranging from $103.35 to $104.05. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Documents
Issuer
Blueprint Medicines Corp
CIK 0001597264
Entity typeother
Related Parties
1- filerCIK 0001756941
Filing Metadata
- Form type
- 4
- Filed
- May 6, 8:00 PM ET
- Accepted
- May 7, 4:32 PM ET
- Size
- 11.2 KB